VFA
NVO

Voya Financial Advisors’s Novo Nordisk NVO Stock Holding History

Voya Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,422
Closed -$626K – 495
2021
Q1 		$626K Sell
18,422
-11,256
-38% -$401K 0.02% 378
2020
Q4 		$1.04M Buy
29,678
+1,514
+5% +$52.3K 0.04% 263
2020
Q3 		$989K Buy
28,164
+898
+3% +$29.9K 0.05% 256
2020
Q2 		$894K Buy
27,266
+322
+1% +$10.3K 0.05% 266
2020
Q1 		$811K Buy
26,944
+2,022
+8% +$60.2K 0.04% 263
2019
Q4 		$719K Buy
24,922
+12,226
+96% +$339K 0.04% 329
2019
Q3 		$328K Buy
12,696
+182
+1% +$4.6K 0.02% 466
2019
Q2 		$318K Sell
12,514
-1,556
-11% -$38.5K 0.02% 475
2019
Q1 		$366K Buy
14,070
+662
+5% +$16.3K 0.02% 436
2018
Q4 		$307K Buy
13,408
+240
+2% +$5.33K 0.02% 427
2018
Q3 		$314K Sell
13,168
-852
-6% -$20.8K 0.02% 467
2018
Q2 		$319K Sell
14,020
-1,562
-10% -$37.1K 0.02% 425
2018
Q1 		$383K Sell
15,582
-454
-3% -$11.9K 0.03% 370
2017
Q4 		$431K Sell
16,036
-144
-0.9% -$3.66K 0.03% 348
2017
Q3 		$389K Sell
16,180
-8,206
-34% -$185K 0.03% 348
2017
Q2 		$517K Sell
24,386
-1,302
-5% -$26.3K 0.04% 289
2017
Q1 		$439K Buy
25,688
+1,202
+5% +$20.9K 0.03% 313
2016
Q4 		$439K Buy
24,486
+7,342
+43% +$133K 0.04% 294
2016
Q3 		$358K Buy
17,144
+746
+5% +$18.5K 0.04% 296
2016
Q2 		$435K Buy
16,398
+18
+0.1% +$494 0.05% 235
2016
Q1 		$444K Buy
16,380
+500
+3% +$13.4K 0.06% 220
2015
Q4 		$466K Sell
15,880
-14
-0.1% -$387 0.07% 207
2015
Q3 		$425K Buy
15,894
+1,158
+8% +$32.8K 0.08% 193
2015
Q2 		$403K Buy
14,736
+442
+3% +$12.4K 0.07% 190
2015
Q1 		$391K Buy
+14,294
New +$329K 0.08% 206

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Voya Financial Advisors's NVO Position: Q2 2021 in Review

Voya Financial Advisors sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 18,422 shares — an estimated $626K sold.

Voya Financial Advisors first reported a position in NVO in Q1 2015 and held it in 25 quarters. The position peaked at $1.04M in Q4 2020. 736 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Voya Financial Advisors reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 18,422 Novo Nordisk shares in Q2 2021, an estimated $626K.
  • Voya Financial Advisors first reported a position in Novo Nordisk in Q1 2015 and held it in 25 quarters.
  • Voya Financial Advisors's Novo Nordisk position peaked at $1.04M in Q4 2020.
  • 736 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.